Ypsilanti teen Abigail Ladd, 15, and her parents Briand and Jennifer Ladd , launched A GoFundMe to raise funds for a service ...
A prospective cohort study of 103 patients in China finds that comorbid headache does not change short-term seizure-free ...
CORE-VNS is the largest prospective, multinational observational study evaluating contemporary VNS Therapy devices in people with Drug-Resistant Epilepsy – Demonstrated 76% median reduction in seizure ...
From a neurological perspective, understanding the different ways seizures present is essential for timely recognition, ...
Rapport Therapeutics reported that RAP-219 achieved statistically significant primary and secondary endpoints in a Phase 2 ...
A groundbreaking medical device that stimulates the brain without opening the skull offers new hope to epilepsy patients who ...
Positive trial data for Rapport’s lead pipeline candidate, RAP-219, a treatment for bipolar mania, points to a potential $1 ...
Rapport's phase 2 bipolar win strikes chord with analysts despite falling short of original ambition
Rapport Therapeutics’ phase 2 bipolar mania study has hit its primary endpoint, furthering the biotech’s efforts to make RAP-219 a multi-indication blockbuster. However, the effect size fell short of ...
Rapport Therapeutics, Inc. announced positive topline results from its Phase 2 trial of RAP-219 in adults experiencing acute mania associated with bipolar I disorder. The trial met its primary ...
One of the Twin Cities’ hottest bands of the past decade played the undersized gig to rally behind Mayo Clinic-bound frontman ...
The trial met the primary and secondary endpoints with statistically significant placebo-adjusted improvements at Week 3 in the YMRS total score ...
A new study from France and Sweden has found a link between epilepsy and dementia developing before age 65, with one specific group facing a sixfold higher risk. However, the actual number of people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results